Evaluating patients' satisfaction and preferences with a secondary prevention cardiovascular polypill: the Aurora Study

J Comp Eff Res. 2021 Sep;10(13):975-985. doi: 10.2217/cer-2021-0105. Epub 2021 Jul 1.

Abstract

Aim: To evaluate the satisfaction, preferences and adherence of patients in secondary cardiovascular prevention treated with the Spanish National Cardiovascular Research Centre cardiovascular polypill compared with patients treated with the separate monocomponents. Methods: Observational, cross-sectional and multicenter study. Satisfaction was evaluated by the Treatment Satisfaction Questionnaire for Medication 9 items, adherence by the Morisky-Green questionnaire and ad-hoc questions were asked regarding patient preferences. Results: Polypill patients reported higher satisfaction than patients treated with the monocomponents (77.3 vs 71.2%; p < 0.0001). 72.8% of patients treated with the monocomponents would prefer to change to the polypill. Patients treated with the polypill had significantly higher adherence than patients treated with the monocomponents (57.7 vs 41.1%; p = 0.0027). Conclusion: Polypill patients show higher satisfaction and better adherence. Most patients receiving the monocomponents would prefer a polypill regime.

Keywords: adherence; cardiovascular; polypill; preferences; prevention; satisfaction.

Publication types

  • Multicenter Study
  • Observational Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antihypertensive Agents
  • Cardiovascular Diseases* / prevention & control
  • Cross-Sectional Studies
  • Drug Combinations
  • Humans
  • Medication Adherence
  • Patient Satisfaction*
  • Secondary Prevention

Substances

  • Antihypertensive Agents
  • Drug Combinations